Equity Research, Broker Reports, and media content on MORPHOSYS AG

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about MORPHOSYS AG
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on MORPHOSYS AG. We currently have 3 research reports from 1 professional analysts.

Date Source Announcement
06Dec16 06:30 GNW MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 2016 Conference:
06Dec16 06:30 GNW MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016
29Nov16 03:00 GNW MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution
28Nov16 11:07 GNW MorphoSys Announces That Its Licensee Janssen Has Submitted a Marketing Authorisation Application For Guselkumab in Europe
25Nov16 01:05 GNW MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution
22Nov16 05:00 GNW Correction of a release from 21.11.2016, 18:05 CET - MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution
21Nov16 05:05 GNW MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution
  • Frequency of research reports

     

  • Research reports on

    MORPHOSYS AG

  • Providers covering

    MORPHOSYS AG

Latest Content

View the latest research, videos, and podcasts for this company.